258 related articles for article (PubMed ID: 15848735)
1. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Zhou M; Roma A; Magi-Galluzzi C
Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
[TBL] [Abstract][Full Text] [Related]
2. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
He H; Zhou GX; Zhou M; Chen L
Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
5. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
6. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
10. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
11. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration.
Yang B; Ali SZ; Rosenthal DL
Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861
[TBL] [Abstract][Full Text] [Related]
12. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
13. CD70: a new tumor specific biomarker for renal cell carcinoma.
Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
[TBL] [Abstract][Full Text] [Related]
14. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma with clear cell and papillary features.
Ross H; Martignoni G; Argani P
Arch Pathol Lab Med; 2012 Apr; 136(4):391-9. PubMed ID: 22458901
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
[TBL] [Abstract][Full Text] [Related]
17. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
Carvalho JC; Wasco MJ; Kunju LP; Thomas DG; Shah RB
Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
[TBL] [Abstract][Full Text] [Related]
18. Profiling and classification tree applied to renal epithelial tumours.
Allory Y; Bazille C; Vieillefond A; Molinié V; Cochand-Priollet B; Cussenot O; Callard P; Sibony M
Histopathology; 2008 Jan; 52(2):158-66. PubMed ID: 18036175
[TBL] [Abstract][Full Text] [Related]
19. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
20. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]